Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides
Motley Fool
Thu, 04/17/14 - 11:49 am
Tags:
Sovaldi, hepatitis C, Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, Express Scripts
Gilead Sciences May See A Healthy Earnings Beat
Seeking Alpha
Wed, 04/16/14 - 05:18 pm
Tags:
earnings, Gilead Sciences
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data
Yahoo/Zacks.com
Wed, 04/16/14 - 10:22 am
Tags:
MannKind, Alkermes, Gilead Sciences, ledipasvir, AbbVie, Afrezza, aripiprazole lauroxil, Pharmacyclics, Imbruvica
Gilead: This Baby Has Been Thrown Away With The Bathwater
Seeking Alpha
Wed, 04/16/14 - 10:19 am
Tags:
Gilead Sciences, Sovaldi
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?
Motley Fool
Tue, 04/15/14 - 10:36 am
Tags:
hepatitis C, Gilead Sciences, Sovaldi, Merck, Bristol-Myers Squibb, daclatasvir, asunaprevir, MK-5172, MK-8742
Price of New Hepatitis C Drugs Not So Daunting After All
Bloomberg
Mon, 04/14/14 - 08:35 am
Tags:
drug pricing, hepatitis C, Sovaldi, Gilead Sciences
Encouraging Results on Gilead's Sovaldi
Yahoo/Zacks
Sat, 04/12/14 - 10:13 am
Tags:
Gilead Sciences, Sovaldi, HCV, hepatitis, hepatitis C
3 Drugs Stocks Driving The Industry Higher
TheStreet.com
Fri, 04/11/14 - 03:41 pm
Tags:
Celgene, Merck, Gilead Sciences
Texas Medicaid holds off on proposed limits for Gilead hepatitis drug
Yahoo/Reuters
Fri, 04/11/14 - 03:38 pm
Tags:
Texas, Gilead Sciences, Medicaid, hepatitis C, Sovaldi
Natco looking to block Indian patent for Gilead's Sovaldi
Fierce Pharma
Fri, 04/11/14 - 11:41 am
Tags:
India, Natco, Gilead Sciences, Sovaldi, hepatitis C
Doctors welcome hepatitis C drug rivals, Gilead still leads
Yahoo/Reuters
Fri, 04/11/14 - 08:47 am
Tags:
physicians, hepatitis C, Gilead Sciences, Sovaldi, Merck, AbbVie, Bristol-Myers Squibb
Gilead Sciences: How Big a Threat is Merck?
Barron's
Thu, 04/10/14 - 10:52 am
Tags:
Gilead Sciences, Merck, hepatitis C, MK-5172, MK-8742, Sovaldi
Gilead Sciences: Pricing Concerns Just Noise?
Barron's
Wed, 04/9/14 - 11:17 am
Tags:
Gilead Sciences, Sovaldi, drug pricing, hepatitis C
WHO joins clamour to make new hepatitis C pills affordable
Yahoo/Reuters
Wed, 04/9/14 - 08:54 am
Tags:
WHO, hepatitis C, Sovaldi, Gilead Sciences
Express Scripts assembling anti-Sovaldi coalition to shut out Gilead hep C drug
Fierce Pharma
Tue, 04/8/14 - 11:50 am
Tags:
Sovaldi, hepatitis C, Gilead Sciences, Express Scripts, drug pricing
Biotechs Struggling To Find A Bottom
Yahoo/Benzinga
Tue, 04/8/14 - 11:29 am
Tags:
biotech, IPOs, drug pricing, Gilead Sciences, Celgene, Biogen Idec, Regeneron, Halozyme
[video]A $1 Trillion Drug Market?
Motley Fool
Tue, 04/8/14 - 10:44 am
Tags:
Gilead Sciences, Solvadi, hepatitis C, hepatitis B
A Physician-Businessman's Views Of Gilead, With Emphasis On Sovaldi
Seeking Alpha
Mon, 04/7/14 - 12:54 pm
Tags:
physicians, Sovaldi, Gilead Sciences, hepatitis C
FirstWord Lists – The Quarterly: 10 key pharma events that occurred in Q1
First Word Pharma
Mon, 04/7/14 - 10:24 am
Tags:
immuno-oncology, Sovaldi, Gilead Sciences, Teva Pharmaceuticals, Copaxone, GSK, Breo Ellipta, Forest Labs, Actavis, M&A, Affordable Care Act, biosimilars, PCSK9 inhibitors
Gilead says Japanese hepatitis C trial meets goal
Yahoo/Reuters
Wed, 04/2/14 - 10:01 pm
Tags:
Gilead Sciences, Japan, hepatitis C, sofosbuvir

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.